Showing results (1531-1540 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|April 17, 2008
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting timeAdriana Balduzzi, Paola De Lorenzo, André Schrauder, et al.
Haematologica|February 13, 2008
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factorIngmar Bruns, Ulrich Steidl, Johannes C Fischer, et al.
Haematologica|February 13, 2008
A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapyWei Li, Shuyang Xie, Xinbing Guo, et al.
Haematologica|June 4, 2008
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumorRita Santachiara, Rossana Maffei, Silvia Martinelli, et al.
Haematologica|November 1, 1990
P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemiaG Carulli, M Petrini, A Marini, et al.
Haematologica|October 10, 2009
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell diseaseEduard J van Beers, Marianne C L Schaap, René J Berckmans, et al.
Haematologica|October 10, 2009
Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell studyLaurent Garderet, Ladan Kobari, Christelle Mazurier, et al.
Haematologica|October 10, 2009
Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cellsMercè de Frias, Daniel Iglesias-Serret, Ana M Cosialls, et al.
Haematologica|August 31, 2019
Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemiaBarbara Mariotti, Giulia Calabretto, Marzia Rossato, et al.
Haematologica|September 14, 2019
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 studyLene Kongsgaard Nielsen, Claudia Stege, Birgit Lissenberg-Witte, et al.
Pageof 815